• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Ultrasound-guided laser targets Europe

Article

Intra-Sonix of Burlington, MA, has initiated clinical trials in Germany and Belgium for itsTulip II ultrasound-guided minimally invasive surgery device.Tulip,an earlier generation product, is already approved for marketin Europe and Japan. Intra-Sonix

Intra-Sonix of Burlington, MA, has initiated clinical trials in Germany and Belgium for itsTulip II ultrasound-guided minimally invasive surgery device.Tulip,an earlier generation product, is already approved for marketin Europe and Japan. Intra-Sonix operates a European subsidiarybased in Leuven, Belgium.

The Tulip procedure -- transurethral ultrasound-guided laser-inducedprostatectomy -- provides treatment of benign prostatic hyperplasia(BPH). Tulip II offers full 360º ultrasound viewing of theprostate along with other system upgrades. Worldwide, more thanone million men undergo surgical treatment of BPH annually, thecompany said.

Use of ultrasound imaging indicates tissue depth and anatomicalfeatures while treating BPH with laser surgery. This can helpsurgeons determine which obstructive prostate tissue to target-- and which not to target -- thus expanding the number of potentiallytreatable prostates. The laser causes necrosis of tissue, whichis subsequently sloughed off in small particles during urination.

Intra-Sonix has also initiated a new six-site U.S. clinicalstudy of Tulip, following reclassification of laser treatmentsfor BPH by the Food and Drug Administration last year. An investigationaldevice exemption application has been filed with the FDA for TulipII.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.